These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 24494653)

  • 1. GES polypharmacology fingerprints: a novel approach for drug repositioning.
    Pérez-Nueno VI; Karaboga AS; Souchet M; Ritchie DW
    J Chem Inf Model; 2014 Mar; 54(3):720-34. PubMed ID: 24494653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting drug promiscuity using Gaussian ensemble screening.
    Pérez-Nueno VI; Venkatraman V; Mavridis L; Ritchie DW
    J Chem Inf Model; 2012 Aug; 52(8):1948-61. PubMed ID: 22747187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring polypharmacology using a ROCS-based target fishing approach.
    AbdulHameed MD; Chaudhury S; Singh N; Sun H; Wallqvist A; Tawa GJ
    J Chem Inf Model; 2012 Feb; 52(2):492-505. PubMed ID: 22196353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessment.
    Salentin S; Haupt VJ; Daminelli S; Schroeder M
    Prog Biophys Mol Biol; 2014; 116(2-3):174-86. PubMed ID: 24923864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polypharmacology: challenges and opportunities in drug discovery.
    Anighoro A; Bajorath J; Rastelli G
    J Med Chem; 2014 Oct; 57(19):7874-87. PubMed ID: 24946140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the Rational Design for Polypharmacology Drug.
    Zhou J; Li Q; Wu M; Chen C; Cen S
    Curr Pharm Des; 2016; 22(21):3182-9. PubMed ID: 26907948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
    Cerisier N; Petitjean M; Regad L; Bayard Q; Réau M; Badel A; Camproux AC
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31295958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ultra-fast 2D and 3D ligand and target descriptors for side effect prediction and network analysis in polypharmacology.
    Cortés-Cabrera A; Morris GM; Finn PW; Morreale A; Gago F
    Br J Pharmacol; 2013 Oct; 170(3):557-67. PubMed ID: 23826885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational polypharmacology: a new paradigm for drug discovery.
    Chaudhari R; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.
    Wei NN; Hamza A
    J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing based on drug-drug interaction.
    Zhou B; Wang R; Wu P; Kong DX
    Chem Biol Drug Des; 2015 Feb; 85(2):137-44. PubMed ID: 24934184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Web-Based Tools for Polypharmacology Prediction.
    Awale M; Reymond JL
    Methods Mol Biol; 2019; 1888():255-272. PubMed ID: 30519952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational application of drug promiscuity in medicinal chemistry.
    Mei Y; Yang B
    Future Med Chem; 2018 Aug; 10(15):1835-1851. PubMed ID: 30019924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances and Challenges in Computational Target Prediction.
    Sydow D; Burggraaff L; Szengel A; van Vlijmen HWT; IJzerman AP; van Westen GJP; Volkamer A
    J Chem Inf Model; 2019 May; 59(5):1728-1742. PubMed ID: 30817146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease network.
    Daminelli S; Haupt VJ; Reimann M; Schroeder M
    Integr Biol (Camb); 2012 Jul; 4(7):778-88. PubMed ID: 22538435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational tools for polypharmacology and repurposing.
    Achenbach J; Tiikkainen P; Franke L; Proschak E
    Future Med Chem; 2011 Jun; 3(8):961-8. PubMed ID: 21707399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LigAdvisor: a versatile and user-friendly web-platform for drug design.
    Pinzi L; Tinivella A; Gagliardelli L; Beneventano D; Rastelli G
    Nucleic Acids Res; 2021 Jul; 49(W1):W326-W335. PubMed ID: 34023895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tools for in silico target fishing.
    Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Pujadas G; Garcia-Vallve S
    Methods; 2015 Jan; 71():98-103. PubMed ID: 25277948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identify drug repurposing candidates by mining the protein data bank.
    Moriaud F; Richard SB; Adcock SA; Chanas-Martin L; Surgand JS; Ben Jelloul M; Delfaud F
    Brief Bioinform; 2011 Jul; 12(4):336-40. PubMed ID: 21768131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward structure-multiple activity relationships (SMARts) using computational approaches: A polypharmacological perspective.
    López-López E; Medina-Franco JL
    Drug Discov Today; 2024 Jul; 29(7):104046. PubMed ID: 38810721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.